Voyager Therapeutics Management
Management criteria checks 2/4
Voyager Therapeutics' CEO is Al Sandrock, appointed in Mar 2022, has a tenure of 2.17 years. total yearly compensation is $3.17M, comprised of 19.7% salary and 80.3% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth $531.01K. The average tenure of the management team and the board of directors is 1.9 years and 4.9 years respectively.
Key information
Al Sandrock
Chief executive officer
US$3.2m
Total compensation
CEO salary percentage | 19.7% |
CEO tenure | 2.2yrs |
CEO ownership | 0.1% |
Management average tenure | 1.9yrs |
Board average tenure | 4.9yrs |
Recent management updates
Recent updates
There's No Escaping Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Muted Revenues Despite A 28% Share Price Rise
Mar 15Voyager Therapeutics: A Tortoise With A Shot At Making Gene Therapy Deliver Easier
Mar 08What Does The Future Hold For Voyager Therapeutics, Inc. (NASDAQ:VYGR)? These Analysts Have Been Cutting Their Estimates
Mar 04Voyager Therapeutics, Inc. (NASDAQ:VYGR) Surges 45% Yet Its Low P/S Is No Reason For Excitement
Jan 04Voyager stock rises as Pfizer opts to use AAV capsid for neurologic disease target
Oct 04Voyager Therapeutics hires new finance chief
Sep 07Voyager Therapeutics GAAP EPS of -$0.50 misses by $0.02
Aug 04Looking Back In On Voyager Therapeutics
Jun 08Need To Know: Analysts Just Made A Substantial Cut To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Estimates
May 12Voyager Does A Reboot After First Generation Failures
Mar 25Companies Like Voyager Therapeutics (NASDAQ:VYGR) Could Be Quite Risky
Feb 07Voyager Therapeutics: Another Year, Another Deal
Nov 21Some Analysts Just Cut Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Estimates
Aug 11Newsflash: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Analysts Have Been Trimming Their Revenue Forecasts
Jul 18CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -US$3m |
Dec 31 2023 | US$3m | US$624k | US$132m |
Sep 30 2023 | n/a | n/a | US$52m |
Jun 30 2023 | n/a | n/a | US$96m |
Mar 31 2023 | n/a | n/a | US$99m |
Dec 31 2022 | US$7m | US$525k | -US$46m |
Compensation vs Market: Al's total compensation ($USD3.17M) is above average for companies of similar size in the US market ($USD2.40M).
Compensation vs Earnings: Al's compensation has been consistent with company performance over the past year.
CEO
Al Sandrock (65 yo)
2.2yrs
Tenure
US$3,172,433
Compensation
Dr. Alfred W. Sandrock Jr., also known as Al, M.D., Ph D., served as Director at Verge Analytics, Inc. since February 2022. He serves as Member of Scientific Advisory Board at Camp4 Therapeutics Corporatio...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 2.2yrs | US$3.17m | 0.12% $ 531.0k | |
COO, Principal Financial & Accounting Officer and Acting Chief Business Officer | less than a year | US$1.38m | 0.062% $ 284.5k | |
Chief Legal Officer | less than a year | US$1.91m | 0% $ 0 | |
Founder | no data | no data | no data | |
Founder & Member of Scientific Advisory Board | no data | no data | no data | |
Founder | no data | no data | no data | |
Founder & Member of Scientific Advisory Board | no data | no data | no data | |
Chief Scientific Officer | 1.7yrs | no data | 0.16% $ 740.5k | |
Chief Human Resources Officer | 3.7yrs | no data | no data | |
Senior Vice President of Translational Medicine & Clinical Development | 3.8yrs | no data | no data | |
Chief Corporate Affairs Officer & Chief of Staff to the CEO | 2.3yrs | no data | no data | |
Chief Medical Officer | less than a year | no data | no data |
1.9yrs
Average Tenure
53yo
Average Age
Experienced Management: VYGR's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 2.3yrs | US$3.17m | 0.12% $ 531.0k | |
Founder & Member of Scientific Advisory Board | no data | no data | no data | |
Founder & Member of Scientific Advisory Board | no data | no data | no data | |
Consultant & Member of Scientific Advisory Board | 4.9yrs | US$1.81m | no data | |
Independent Director | 10.3yrs | US$263.78k | 0.10% $ 461.3k | |
Independent Director | 7.3yrs | US$248.78k | 0.040% $ 184.1k | |
Independent Director | 8.7yrs | US$255.78k | 0% $ 0 | |
Independent Chairman of the Board | 8.8yrs | US$281.28k | 0.058% $ 264.6k | |
Independent Director | 1.8yrs | US$250.78k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 1.3yrs | US$432.23k | 0% $ 0 | |
Independent Director | 3.7yrs | US$255.28k | 0% $ 0 |
4.9yrs
Average Tenure
65yo
Average Age
Experienced Board: VYGR's board of directors are considered experienced (4.9 years average tenure).